Nicolas Cabrit

Presentation(s):

• SO-5: Disease-free survival as surrogate for overall survival in neoadjuvant chemo(radio)therapy treatment of esophageal or gastro-esophageal junction carcinoma: an analysis of 4518 individual patients and 22 trials

  Thursday, June 30, 2022
  08:08 – 08:16